<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>Name:</title></head><body><div><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p><h1 style="margin:12pt 0pt 3pt; page-break-after:avoid; text-align:center"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">Written evidence submitted by the National Farmers Union (NFU)</span><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold"> (AMR0055)</span></h1><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Executive Summary</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU recognises the importance of antimicrobial resistance as a fundamental threat to animals and humans </span><span style="font-family:'Times New Roman'; font-size:11pt">alike.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU believes that antimicrobials are a precious resource and their effectiveness must be protected.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Scientific evidence increasingly recognises that the problem of antimicrobial resistance in humans is a consequence of irresponsible use of </span><span style="font-family:'Times New Roman'; font-size:11pt">antimicrobials in human medicine.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Minimising the risk of disease on farm through the development and implementation of farm health planning and disease reduction strategies are an important aspect of reducing the need </span><span style="font-family:'Times New Roman'; font-size:11pt">for</span><span style="font-family:'Times New Roman'; font-size:11pt"> antimicrobials</span><span style="font-family:'Times New Roman'; font-size:11pt"> on farm</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">Even wi</span><span style="font-family:'Times New Roman'; font-size:11pt">th the best of care however, farm animals will still get sick and may need antimicrobial treatment. </span><span style="font-family:'Times New Roman'; font-size:11pt">These anti</span><span style="font-family:'Times New Roman'; font-size:11pt">microbials</span><span style="font-family:'Times New Roman'; font-size:11pt"> are available only with a veterinary prescription and it is the veterinary surgeon who decides what to administer and when to use them.</span><span style="font-family:'Times New Roman'; font-size:11pt"> The livestock keeper must ensure that these instructions are adhered to</span><span style="font-family:'Times New Roman'; font-size:11pt">, as well as meeting regulatory commitments such as recording the use and treatment regime</span><span style="font-family:'Times New Roman'; font-size:11pt">.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU fundamentally supports the principle of responsible use of antimicrobials which mea</span><span style="font-family:'Times New Roman'; font-size:11pt">ns using them as little as possible and as much as necessary.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU feels that </span><span style="font-family:'Times New Roman'; font-size:11pt">the UK’s intervention strategy for reducing the impact and development of </span><span style="font-family:'Times New Roman'; font-size:11pt">antimicrobial</span><span style="font-family:'Times New Roman'; font-size:11pt"> resistance hinge</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> around identifying a</span><span style="font-family:'Times New Roman'; font-size:11pt">nd avoiding high risk practices, and believes th</span><span style="font-family:'Times New Roman'; font-size:11pt">at</span><span style="font-family:'Times New Roman'; font-size:11pt"> this is where the responsible use principles</span><span style="font-family:'Times New Roman'; font-size:11pt">, as developed and promoted by RUMA,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">should be fully supported.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU is opposed to setting targets or level of use restrictions</span><span style="font-family:'Times New Roman'; font-size:11pt">, as implemented in some other EU Member States</span><span style="font-family:'Times New Roman'; font-size:11pt">. Reducing dosages or the lengt</span><span style="font-family:'Times New Roman'; font-size:11pt">h of treatment simply to use a lesser quantity of anti</span><span style="font-family:'Times New Roman'; font-size:11pt">microbials</span><span style="font-family:'Times New Roman'; font-size:11pt"> to meet reduction targets is not responsible use. It could in fact encourage the development of </span><span style="font-family:'Times New Roman'; font-size:11pt">antimicrobial</span><span style="font-family:'Times New Roman'; font-size:11pt"> resistance</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> compro</span><span style="font-family:'Times New Roman'; font-size:11pt">mise animal health and welfare and encourage illegal practices.</span></p><p style="margin:0pt 0pt 0pt 36.15pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Introduction</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-weight:bold">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU is the largest </span><span style="font-family:'Times New Roman'; font-size:11pt">farming representative organisation</span><span style="font-family:'Times New Roman'; font-size:11pt"> in Great Britain</span><span style="font-family:'Times New Roman'; font-size:11pt"> with </span><span style="font-family:'Times New Roman'; font-size:11pt">more than 55,000 farming members in England and Wales. In addition we have 41,000 countryside members with an inter</span><span style="font-family:'Times New Roman'; font-size:11pt">est in farming and the country.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU’s </span><span style="font-family:'Times New Roman'; font-size:11pt">membership takes pride</span><span style="font-family:'Times New Roman'; font-size:11pt"> in having some of the highest standards of animal health and w</span><span style="font-family:'Times New Roman'; font-size:11pt">elfare, food safety and hygiene across Europe,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and the NFU believes that </span><span style="font-family:'Times New Roman'; font-size:11pt">the UK’s</span><span style="font-family:'Times New Roman'; font-size:11pt"> responsible use </span><span style="font-family:'Times New Roman'; font-size:11pt">principles for anti</span><span style="font-family:'Times New Roman'; font-size:11pt">microbials</span><span style="font-family:'Times New Roman'; font-size:11pt"> help</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">to</span><span style="font-family:'Times New Roman'; font-size:11pt"> achieve </span><span style="font-family:'Times New Roman'; font-size:11pt">and retain </span><span style="font-family:'Times New Roman'; font-size:11pt">this status.  </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU is a founding member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and RUMA’s values and principles of responsible use are embedded into NFU policy on veterinary medicine use and animal health and welfare.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The RUMA initiative </span><span style="font-family:'Times New Roman'; font-size:11pt">promotes the responsible use message to industry professionals through the provisio</span><span style="font-family:'Times New Roman'; font-size:11pt">n of sector-specific guidelines -</span><span style="font-family:'Times New Roman'; font-size:11pt"> an approach that the NFU supports. Similar </span><span style="font-family:'Times New Roman'; font-size:11pt">initiatives are being adopted in Europe with RUMA’s counterpart, EPRUMA</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and again, the NFU supp</span><span style="font-family:'Times New Roman'; font-size:11pt">orts these advances. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU believes that anti</span><span style="font-family:'Times New Roman'; font-size:11pt">biotics are precious resources which are</span><span style="font-family:'Times New Roman'; font-size:11pt"> essential for the treatment of bacterial infections in food-producing animals.  </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="6" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU accepts that the development of bacterial resistance to antibiotics is a thr</span><span style="font-family:'Times New Roman'; font-size:11pt">eat to both animal and human medicine but stresses that the majority of the science implies that resistance in bacteria </span><span style="font-family:'Times New Roman'; font-size:11pt">which</span><span style="font-family:'Times New Roman'; font-size:11pt"> infect humans is caused by the human misuse of antibiotics.  </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="7" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The link between the spread of resistance from animal bacterial str</span><span style="font-family:'Times New Roman'; font-size:11pt">ains to human ones is not </span><span style="font-family:'Times New Roman'; font-size:11pt">scientifically </span><span style="font-family:'Times New Roman'; font-size:11pt">significant, and there is little evidence that bans on certain classes of antibiotic</span><span style="font-family:'Times New Roman'; font-size:11pt">s,</span><span style="font-family:'Times New Roman'; font-size:11pt"> or reductions in levels of antibiotics used would have any effect.  </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="8" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The </span><span style="font-family:'Times New Roman'; font-size:11pt">use of farm health planning</span><span style="font-family:'Times New Roman'; font-size:11pt">, in conjunction with the f</span><span style="font-family:'Times New Roman'; font-size:11pt">arm vet is recommended </span><span style="font-family:'Times New Roman'; font-size:11pt">to aid the responsible</span><span style="font-family:'Times New Roman'; font-size:11pt"> use of antibiotics and medicines: </span><span style="font-family:'Times New Roman'; font-size:11pt">‘</span><span style="font-family:'Times New Roman'; font-size:11pt">prevention is better than cure</span><span style="font-family:'Times New Roman'; font-size:11pt">’</span><span style="font-family:'Times New Roman'; font-size:11pt">.  The NFU encourages its membership to embrace this, and for all farms to develop a bespoke </span><span style="font-family:'Times New Roman'; font-size:11pt">farm health planning </span><span style="font-family:'Times New Roman'; font-size:11pt">strategy covering biosecurity, vaccination and worming programmes.  This should be regularly reviewed to ensure that the developing needs of the farm are met.  </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="9" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 31.25pt; padding-left:4.75pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It is vitally important that where medicines are prescribed by a vet, </span><span style="font-family:'Times New Roman'; font-size:11pt">they are</span><span style="font-family:'Times New Roman'; font-size:11pt"> administered fo</span><span style="font-family:'Times New Roman'; font-size:11pt">llowing the vet’s recommendations for dosage, treatment regime and treatment duration.  </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="10" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU feels that implementing reactive changes to the way in which the UK uses </span><span style="font-family:'Times New Roman'; font-size:11pt">antimicrobials</span><span style="font-family:'Times New Roman'; font-size:11pt"> in farm animals would be an unnecessary and fruitless investment.  </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="11" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">he NFU is proactively involved in EU lobbying at a number of levels</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> working closely with European counterparts to influence both the European Commission and </span><span style="font-family:'Times New Roman'; font-size:11pt">the European Parliament</span><span style="font-family:'Times New Roman'; font-size:11pt"> to develop policy which is science-led and reflects </span><span style="font-family:'Times New Roman'; font-size:11pt">responsible </span><span style="font-family:'Times New Roman'; font-size:11pt">use </span><span style="font-family:'Times New Roman'; font-size:11pt">princi</span><span style="font-family:'Times New Roman'; font-size:11pt">ples</span><span style="font-family:'Times New Roman'; font-size:11pt">.   </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="12" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The </span><span style="font-family:'Times New Roman'; font-size:11pt">NFU </span><span style="font-family:'Times New Roman'; font-size:11pt">is working with</span><span style="font-family:'Times New Roman'; font-size:11pt"> Copa Cogeca</span><span style="font-family:'Times New Roman'; font-size:11pt">, the pan European representative body of EU farming and co-operative organisations</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">to </span><span style="font-family:'Times New Roman'; font-size:11pt">encourage its members to adopt</span><span style="font-family:'Times New Roman'; font-size:11pt"> farm health planning and to develop their own responsible use guidelines to counter the argu</span><span style="font-family:'Times New Roman'; font-size:11pt">ments that antibiotics are propping up bad welfare.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="13" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU does not recognise that the scale of a farm enterprise is a contributory factor to the development of antimicrobial resistance or a precursor to irresponsible or over-use of antimicrobials. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Antimicrobials should not be used a prop </span><span style="font-family:'Times New Roman'; font-size:11pt">for</span><span style="font-family:'Times New Roman'; font-size:11pt"> poor husbandry or welfare systems, but as a </span><span style="font-family:'Times New Roman'; font-size:11pt">necessary counter to a microbial disease or illness and always under veterinary prescription. </span><span style="font-family:'Times New Roman'; font-size:11pt"> </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="15" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Antimicrobials are expensive and it is not in the best interest of the</span><span style="font-family:'Times New Roman'; font-size:11pt"> farm business to use these medicines without genuine reason.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="16" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU’s comments on the terms of reference, on which written evidence is sought, are set out in the following paragraphs.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">How has antimicrobial resistance developed in the past decade?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="17" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It i</span><span style="font-family:'Times New Roman'; font-size:11pt">s recognised that antimicrobial resistance has been a naturally occurring phenomena for as long as we have recognised antimicrobial elements and their action on </span><span style="font-family:'Times New Roman'; font-size:11pt">microbes</span><span style="font-family:'Times New Roman'; font-size:11pt">. Certain elements of modern life have helped to spread and potentially accelerate the </span><span style="font-family:'Times New Roman'; font-size:11pt">development of antimicrobial resistance</span><span style="font-family:'Times New Roman'; font-size:11pt"> however</span><span style="font-family:'Times New Roman'; font-size:11pt"> (for example </span><span style="font-family:'Times New Roman'; font-size:11pt">increased</span><span style="font-family:'Times New Roman'; font-size:11pt"> access to hospitals and medical </span><span style="font-family:'Times New Roman'; font-size:11pt">treatment and global </span><span style="font-family:'Times New Roman'; font-size:11pt">movement of people, food and animals</span><span style="font-family:'Times New Roman'; font-size:11pt">) so this question, although a </span><span style="font-family:'Times New Roman'; font-size:11pt">seemingly</span><span style="font-family:'Times New Roman'; font-size:11pt"> straightforward one, highlights certain complexities in </span><span style="font-family:'Times New Roman'; font-size:11pt">providing</span><span style="font-family:'Times New Roman'; font-size:11pt"> an answer.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="18" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The primary </span><span style="font-family:'Times New Roman'; font-size:11pt">target</span><span style="font-family:'Times New Roman'; font-size:11pt"> of the </span><span style="font-family:'Times New Roman'; font-size:11pt">recent </span><span style="font-family:'Times New Roman'; font-size:11pt">debate</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">on</span><span style="font-family:'Times New Roman'; font-size:11pt"> antimicrobial resistance amongst </span><span style="font-family:'Times New Roman'; font-size:11pt">g</span><span style="font-family:'Times New Roman'; font-size:11pt">lobal policy organisations (the European Commission, European Parliament, individual Governments, t</span><span style="font-family:'Times New Roman'; font-size:11pt">he World Health Organisation and the OiE) is largely around </span><span style="font-family:'Times New Roman'; font-size:11pt">preserving</span><span style="font-family:'Times New Roman'; font-size:11pt"> the</span><span style="font-family:'Times New Roman'; font-size:11pt"> effectiveness of antibiotics to treat h</span><span style="font-family:'Times New Roman'; font-size:11pt">uman bacterial illnesses</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and</span><span style="font-family:'Times New Roman'; font-size:11pt"> the </span><span style="font-family:'Times New Roman'; font-size:11pt">prevention of </span><span style="font-family:'Times New Roman'; font-size:11pt">development an</span><span style="font-family:'Times New Roman'; font-size:11pt">d</span><span style="font-family:'Times New Roman'; font-size:11pt"> spread of </span><span style="font-family:'Times New Roman'; font-size:11pt">resistant bacteria amongst the human population. </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="19" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">This is evidenced</span><span style="font-family:'Times New Roman'; font-size:11pt"> by the </span><span style="font-family:'Times New Roman'; font-size:11pt">concern and awareness of the growing </span><span style="font-family:'Times New Roman'; font-size:11pt">prevalence of the ‘super bug’ type bacteria </span><span style="font-family:'Times New Roman'; font-size:11pt">such as MRSA</span><span style="font-family:'Times New Roman'; font-size:11pt">;</span><span style="font-family:'Times New Roman'; font-size:11pt"> increasing</span><span style="font-family:'Times New Roman'; font-size:11pt">ly</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">acquired in hospitals and community care environments</span><span style="font-family:'Times New Roman'; font-size:11pt"> among</span><span style="font-family:'Times New Roman'; font-size:11pt">st</span><span style="font-family:'Times New Roman'; font-size:11pt"> the human population. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="20" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">A</span><span style="font-family:'Times New Roman'; font-size:11pt">ntibiotic resistance is </span><span style="font-family:'Times New Roman'; font-size:11pt">undoubtedly </span><span style="font-family:'Times New Roman'; font-size:11pt">a global problem,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">but its prevalence is not uniform</span><span style="font-family:'Times New Roman'; font-size:11pt">ly spread</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span><span style="font-family:'Times New Roman'; font-size:11pt">V</span><span style="font-family:'Times New Roman'; font-size:11pt">ancomycin resistant enterococci (VRE) are a major </span><span style="font-family:'Times New Roman'; font-size:11pt">concern</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the USA, but the problem is not so great in Western Europe. This can be explained by the intensive human use of vancomycin in the USA over the past 1</span><span style="font-family:'Times New Roman'; font-size:11pt">5 years. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="21" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Antibiotic resistance genes have been found in animal zoonotics. (Zoonoses are types of bacteria found in both humans and animals, and there are some very well-known examples such as </span><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">Salmonella, E.coli and S.aureus</span><span style="font-family:'Times New Roman'; font-size:11pt">)</span><span style="font-family:'Times New Roman'; font-size:11pt">. The NFU recognises the</span><span style="font-family:'Times New Roman'; font-size:11pt"> risk that humans could be infected by resistant zoonotic pathogens, and that </span><span style="font-family:'Times New Roman'; font-size:11pt">these</span><span style="font-family:'Times New Roman'; font-size:11pt"> could drive</span><span style="font-family:'Times New Roman'; font-size:11pt"> a transfer of resistant bacteria through the food chain or the environment. </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="22" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Scientific evidence increasingly recognises that the problem of antibiotic </span><span style="font-family:'Times New Roman'; font-size:11pt">resistance in humans comes largely from the use</span><span style="font-family:'Times New Roman'; font-size:11pt">, or mis-use,</span><span style="font-family:'Times New Roman'; font-size:11pt"> of antibiotic</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> in human medicine and t</span><span style="font-family:'Times New Roman'; font-size:11pt">he medical profession is working to improve </span><span style="font-family:'Times New Roman'; font-size:11pt">its record of </span><span style="font-family:'Times New Roman'; font-size:11pt">responsible </span><span style="font-family:'Times New Roman'; font-size:11pt">stewardship</span><span style="font-family:'Times New Roman'; font-size:11pt"> in the human sector</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="23" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The farming sector is fully aware of its responsibil</span><span style="font-family:'Times New Roman'; font-size:11pt">ities to use veterinary medicines and antibiotics responsibly</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> but stresses that any controls or actions must be proportionate to the risk</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and mindful of the sentient status of animals </span><span style="font-family:'Times New Roman'; font-size:11pt">and their rights to be treated appropriately when</span><span style="font-family:'Times New Roman'; font-size:11pt"> faced with bacterial</span><span style="font-family:'Times New Roman'; font-size:11pt"> infections.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="24" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU is aware that RUMA, in its written evidence </span><span style="font-family:'Times New Roman'; font-size:11pt">submission</span><span style="font-family:'Times New Roman'; font-size:11pt">, has described the difficulties in measuring</span><span style="font-family:'Times New Roman'; font-size:11pt"> and comparing</span><span style="font-family:'Times New Roman'; font-size:11pt"> resistance</span><span style="font-family:'Times New Roman'; font-size:11pt"> in human and animal sectors</span><span style="font-family:'Times New Roman'; font-size:11pt"> caused by incomparable</span><span style="font-family:'Times New Roman'; font-size:11pt"> scientific cut off points and definitions.</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">The NFU agree</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> with</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and support</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> RUMA’s comments</span><span style="font-family:'Times New Roman'; font-size:11pt">, </span><span style="font-family:'Times New Roman'; font-size:11pt">so</span><span style="font-family:'Times New Roman'; font-size:11pt"> will not duplicate them here.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What are the gaps in our knowledge about antimicrobial resistance?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="25" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Further research is needed to understand the pathways and drivers of antimicrobial resistance. The contribution of en</span><span style="font-family:'Times New Roman'; font-size:11pt">vironmental pathways of resistance for example is still poorly understood and yet </span><span style="font-family:'Times New Roman'; font-size:11pt">could be hugely important.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="26" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">We need to understand more about the transfer and effect of resistance from human to animals and vice versa</span><span style="font-family:'Times New Roman'; font-size:11pt">. This would allow us</span><span style="font-family:'Times New Roman'; font-size:11pt"> to assess the</span><span style="font-family:'Times New Roman'; font-size:11pt"> pro</span><span style="font-family:'Times New Roman'; font-size:11pt">bability</span><span style="font-family:'Times New Roman'; font-size:11pt"> or capacity of</span><span style="font-family:'Times New Roman'; font-size:11pt"> anti</span><span style="font-family:'Times New Roman'; font-size:11pt">microbial</span><span style="font-family:'Times New Roman'; font-size:11pt"> resistance genes in the animal reservoir </span><span style="font-family:'Times New Roman'; font-size:11pt">to contribute significantly</span><span style="font-family:'Times New Roman'; font-size:11pt"> to the problem of resistance</span><span style="font-family:'Times New Roman'; font-size:11pt"> in human pathogens.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><br style="page-break-before:always; clear:both" /><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">Is there sufficient research and investment into new antibiotics or other treatments and methods to</span><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps"> ensure continued protection against infection? If not, how could this be rectified?</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="27" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The market and product portfolio</span><span style="font-family:'Times New Roman'; font-size:11pt">s for new antimicrobials have</span><span style="font-family:'Times New Roman'; font-size:11pt"> become fairly static over the last 10 years resulting in a significant decrease in the number of new actives</span><span style="font-family:'Times New Roman'; font-size:11pt"> released onto the market.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="28" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU cannot speculate on the pharmaceutical industry’s ability or willingness to invest in new product development but conversations and debates that we have been party to, suggest that there are serious problems in terms of </span><span style="font-family:'Times New Roman'; font-size:11pt">investment potential and risk. The development of a new antimicrobial from inception to licencing </span><span style="font-family:'Times New Roman'; font-size:11pt">represents a significant financial and time investment</span><span style="font-family:'Times New Roman'; font-size:11pt">. This </span><span style="font-family:'Times New Roman'; font-size:11pt">is</span><span style="font-family:'Times New Roman'; font-size:11pt"> against a backdrop of uncertainty that the product </span><span style="font-family:'Times New Roman'; font-size:11pt">would</span><span style="font-family:'Times New Roman'; font-size:11pt"> be allowed full market access</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> or </span><span style="font-family:'Times New Roman'; font-size:11pt">wou</span><span style="font-family:'Times New Roman'; font-size:11pt">ld </span><span style="font-family:'Times New Roman'; font-size:11pt">even </span><span style="font-family:'Times New Roman'; font-size:11pt">still be </span><span style="font-family:'Times New Roman'; font-size:11pt">needed. New business models are </span><span style="font-family:'Times New Roman'; font-size:11pt">required</span><span style="font-family:'Times New Roman'; font-size:11pt"> that help to ince</span><span style="font-family:'Times New Roman'; font-size:11pt">ntivise new product development</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and provide reassurance that long term investments will be rewarded.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="29" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Alternative treatments such as vaccines and bacteriophages </span><span style="font-family:'Times New Roman'; font-size:11pt">seem to have </span><span style="font-family:'Times New Roman'; font-size:11pt">potential but they too can be hampered by the same issues as highlighted in the previous paragraph.</span></li></ol><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to </span><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">control other pathogens?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="30" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Some European Member States have attempted to control or reduce the use of antimicrobials in the farming sector by setting </span><span style="font-family:'Times New Roman'; font-size:11pt">targets and level of use restrictions, with arbitrary levels set which have no scientific or evidential bas</span><span style="font-family:'Times New Roman'; font-size:11pt">is. </span><span style="font-family:'Times New Roman'; font-size:11pt">There is little </span><span style="font-family:'Times New Roman'; font-size:11pt">proof</span><span style="font-family:'Times New Roman'; font-size:11pt"> that these are having any positive impact on levels of resistance and increasing concerns that disease prevalence rates</span><span style="font-family:'Times New Roman'; font-size:11pt"> amongst animals</span><span style="font-family:'Times New Roman'; font-size:11pt"> are in fact increasing. Anecdotal comments from some of our farming equivalents throughout Eur</span><span style="font-family:'Times New Roman'; font-size:11pt">ope also suggest that Black Markets </span><span style="font-family:'Times New Roman'; font-size:11pt">selling</span><span style="font-family:'Times New Roman'; font-size:11pt"> veterinary antibiotics are growing in response to farmers’ reluctance to access antibiotics legitimately for fear of positioning themselves as ‘high users’</span><span style="font-family:'Times New Roman'; font-size:11pt"> and thereby exposing themselves to potentially damaging </span><span style="font-family:'Times New Roman'; font-size:11pt">business restrictions or penalties</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="31" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU </span><span style="font-family:'Times New Roman'; font-size:11pt">is</span><span style="font-family:'Times New Roman'; font-size:11pt"> opposed </span><span style="font-family:'Times New Roman'; font-size:11pt">to setting targets or level of use restrictions</span><span style="font-family:'Times New Roman'; font-size:11pt">. Reducing dosages or the length of treatment simply to use a lesser quantity of antibiotics to meet reduction targets is not responsible use. It could </span><span style="font-family:'Times New Roman'; font-size:11pt">in fact encourage the development of antibiotic resistance and compromise animal health and welfare. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="32" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It is through using medicines responsibly that we can preserve their effectiveness and protect the health and welfare of our animals, and communities.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="33" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">T</span><span style="font-family:'Times New Roman'; font-size:11pt">he NFU feels that </span><span style="font-family:'Times New Roman'; font-size:11pt">the UK’s intervention strategy for reducing the impact and development of anti</span><span style="font-family:'Times New Roman'; font-size:11pt">microbial</span><span style="font-family:'Times New Roman'; font-size:11pt"> resistance hinge</span><span style="font-family:'Times New Roman'; font-size:11pt">s</span><span style="font-family:'Times New Roman'; font-size:11pt"> around identifying a</span><span style="font-family:'Times New Roman'; font-size:11pt">nd avoiding high risk practices, and we believe that</span><span style="font-family:'Times New Roman'; font-size:11pt"> this is where the responsible use principles</span><span style="font-family:'Times New Roman'; font-size:11pt">, as developed </span><span style="font-family:'Times New Roman'; font-size:11pt">and promoted by RUMA,</span><span style="font-family:'Times New Roman'; font-size:11pt"> </span><span style="font-family:'Times New Roman'; font-size:11pt">should be fully supported.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="34" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Fundamentally, </span><span style="font-family:'Times New Roman'; font-size:11pt">t</span><span style="font-family:'Times New Roman'; font-size:11pt">he NFU feels that </span><span style="font-family:'Times New Roman'; font-size:11pt">all medicines on farm should be used as little as possible </span><span style="font-family:'Times New Roman'; font-size:11pt">and</span><span style="font-family:'Times New Roman'; font-size:11pt"> as much as necessary. This means managing the farm to reduce the risk of disease challenge, using medicines o</span><span style="font-family:'Times New Roman'; font-size:11pt">nly when required and then using them appropriately. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="35" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">It must be remembered that under UK and EU animal welfare legislation, farmers are legally required to ensure that animals receive appropriate treatment if they become sick. Removing their ability to </span><span style="font-family:'Times New Roman'; font-size:11pt">do this would negatively affect animal welfare. This would be unacceptable.</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="36" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Antimicrobial resistance is a global problem which needs global solutions implemented in a local situation. Infrastructure </span><span style="font-family:'Times New Roman'; font-size:11pt">failings</span><span style="font-family:'Times New Roman'; font-size:11pt"> and poverty are major obstacles to overcome</span><span style="font-family:'Times New Roman'; font-size:11pt">,</span><span style="font-family:'Times New Roman'; font-size:11pt"> and </span><span style="font-family:'Times New Roman'; font-size:11pt">the ability to introduce regulatory frameworks to tackle irresponsible or i</span><span style="font-family:'Times New Roman'; font-size:11pt">llegal use of antimicrobials </span><span style="font-family:'Times New Roman'; font-size:11pt">has</span><span style="font-family:'Times New Roman'; font-size:11pt"> present</span><span style="font-family:'Times New Roman'; font-size:11pt">ed</span><span style="font-family:'Times New Roman'; font-size:11pt"> too much of a challenge for some </span><span style="font-family:'Times New Roman'; font-size:11pt">developing </span><span style="font-family:'Times New Roman'; font-size:11pt">countries</span><span style="font-family:'Times New Roman'; font-size:11pt"> so far</span><span style="font-family:'Times New Roman'; font-size:11pt">. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="37" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">There </span><span style="font-family:'Times New Roman'; font-size:11pt">have been recent commitments </span><span style="font-family:'Times New Roman'; font-size:11pt">though </span><span style="font-family:'Times New Roman'; font-size:11pt">from the WHO, the OiE and the Europ</span><span style="font-family:'Times New Roman'; font-size:11pt">ean Commission to come together to find global solutions. The recent Cha</span><span style="font-family:'Times New Roman'; font-size:11pt">tham House Conference on AMR (October 2013) which brought together human and veterinary sector representatives from around the World presented the UK’s Chief Medical Officer, Professor Dame Sally Davies, with a challenge to lead the medical profession’s re</span><span style="font-family:'Times New Roman'; font-size:11pt">sponse whilst the UK’s Veterinary Medicines Directora</span><span style="font-family:'Times New Roman'; font-size:11pt">te, which</span><span style="font-family:'Times New Roman'; font-size:11pt"> chairs the EU’s Head of Medicines (Regulatory) Agencies’ Veterinary Task Force on Antimicrobial Resistance, is also working co</span><span style="font-family:'Times New Roman'; font-size:11pt">llaboratively </span><span style="font-family:'Times New Roman'; font-size:11pt"> to develop models across Europe for more harmonised </span><span style="font-family:'Times New Roman'; font-size:11pt">data collection. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="38" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU, as mentioned previously, is a member </span><span style="font-family:'Times New Roman'; font-size:11pt">of RUMA and EPRUMA through its membership of Copa Cogeca. Through thes</span><span style="font-family:'Times New Roman'; font-size:11pt">e bodies, the NFU is </span><span style="font-family:'Times New Roman'; font-size:11pt">working to increase the use and uptake of farm health planning across EU farming sectors with the ai</span><span style="font-family:'Times New Roman'; font-size:11pt">m of improving the overall health of the EU’s farm animals, and therefore reducing the need to use veterinary medicines. Part of this effort is promoting the </span><span style="font-family:'Times New Roman'; font-size:11pt">adoption of the UK’s </span><span style="font-family:'Times New Roman'; font-size:11pt">responsible use principles. </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">What are the strengths and weaknesses of the Go</span><span style="font-family:'Times New Roman'; font-size:11pt; font-variant:small-caps">vernment’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="39" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">The NFU is fully supportive of the Government’s strategy and feels that it presents a well-balanced documen</span><span style="font-family:'Times New Roman'; font-size:11pt">t with appropriate challenges to all involved.</span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="40" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">In order to maintain momentum however, the Government needs to engage further with industry stakeholders such as the NFU, RUMA, the veterinary profession, etc, to develop concepts and timeframes against which</span><span style="font-family:'Times New Roman'; font-size:11pt"> progress can be measured. </span></li></ol><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><ol start="41" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:'Times New Roman'; font-size:11pt; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:0pt"><span style="font-family:'Times New Roman'; font-size:11pt">Financial support </span><span style="font-family:'Times New Roman'; font-size:11pt">from the public purse </span><span style="font-family:'Times New Roman'; font-size:11pt">must also be considered. Organisations such as RUMA have huge potential to meet many of the challenges posed for the farming sector, but are hampered by lack of funding. There would be a definite public good benefit in the veterinary / farming sector meeti</span><span style="font-family:'Times New Roman'; font-size:11pt">ng their specific challenges so public funding would be justified.  </span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:'Times New Roman'; font-size:11pt; font-style:italic">November 2013</span></p><p style="margin:0pt"><span style="font-family:Arial; font-size:11pt">&#xa0;</span></p></div></body></html>